SNN - Smith & Nephew plc

NYSE - NYSE Delayed Price. Currency in USD
35.19
-0.23 (-0.65%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close35.42
Open34.91
Bid0.00 x 1800
Ask0.00 x 800
Day's Range34.83 - 35.24
52 Week Range33.79 - 40.43
Volume471,990
Avg. Volume536,670
Market Cap15.891B
Beta0.25
PE Ratio (TTM)20.06
EPS (TTM)1.75
Earnings DateN/A
Forward Dividend & Yield0.70 (1.95%)
Ex-Dividend Date2018-04-05
1y Target Est40.57
Trade prices are not sourced from all markets
  • Benzinga4 days ago

    AxisWire: Cannabis Companies Are Moving To Canada, Its Friendlier Legal Climate

    Canada possesses more short-term advantages for going public, as cannabis business owners benefit from operating in a market that carries little legal risk. “Sure, nine states have legalized recreational cannabis, but it’s still federally illegal. Canadian company Sunniva, Inc. (CNSX: SNN) plans to obtain licensing in both Canada and California, making it one of the first cannabis companies operating in both regions.

  • Reuters21 days ago

    Smith & Nephew buoyed by recovery in U.S. market

    Smith & Nephew's new chief executive confirmed the company's full-year guidance on Thursday after improvement in its U.S. market helped revenues for the artificial hip and knee maker to recover from a tough start to the year. Smith & Nephew (SN.L) said underlying revenue growth for the year was still expected to be 2-3 percent, after it cut its outlook in its previous trading statement in May, one of the last acts of its previous CEO. New boss Namal Nawana said that while Europe remained soft, there had been improvement in the United States, where the company derives about half of its revenues.

  • PR Newswire22 days ago

    JOURNEY™ II BCS Knee System demonstrates improved patient outcomes and lower healthcare costs

    LONDON , July 25, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced positive clinical results concerning its JOURNEY™ II Bi-Cruciate Stabilized ...

  • ACCESSWIRE27 days ago

    Today’s Free Research Reports Coverage on Neovasc and Three More Healthcare Stocks

    Under assessment this morning are these four equities: Myomo Inc. (NYSE AMER: MYO), Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), and Insulet Corp. (NASDAQ: PODD). All you have to do is sign up today for this free limited time offer by clicking the link below.

  • PR Newswirelast month

    UK’s NICE Publishes a Medtech Innovation Briefing on PICO™ for the Prophylactic Use in Surgically Closed Incisions to Reduce Surgical Site Complications

    LONDON and NEW YORK , July 3, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN) (NYSE: SNN), the global medical technology business, announces that the UK's National Institute for Health and Care Excellence ...

  • ACCESSWIRE2 months ago

    Neovasc and Three Additional Medical Appliances & Equipment Stocks on Our Research Desk’s Radar

    This Monday, WallStEquities.com has initiated reports coverage on the following Medical Appliances & Equipment equities: Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), Accuray Inc. (NASDAQ: ARAY), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). All you have to do is sign up today for this free limited time offer by clicking the link below.

  • Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.2 months ago

    Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?

    The size of Smith & Nephew plc (LSE:SN.), a UK£11.91B large-cap, often attracts investors seeking a reliable investment in the stock market. Big corporations are much sought after by risk-averseRead More...

  • Reuters3 months ago

    Outgoing Smith & Nephew CEO signs off with a downgrade

    Smith & Nephew downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted. Bohuon, who steps down on Monday, said the business had seen a "mixed performance" in the quarter to end-March, with established markets like the United States and Europe down 2 percent on an underlying basis and emerging markets up 9 percent, resulting in a flat result overall.

  • Does Smith & Nephew plc’s (LON:SN.) PE Ratio Warrant A Buy?
    Simply Wall St.4 months ago

    Does Smith & Nephew plc’s (LON:SN.) PE Ratio Warrant A Buy?

    Smith & Nephew plc (LSE:SN.) trades with a trailing P/E of 21.7x, which is lower than the industry average of 29.6x. While this makes SN. appear like a great stockRead More...

  • Smith & Nephew plc (LON:SN.) Delivered A Better ROE Than The Industry, Here’s Why
    Simply Wall St.4 months ago

    Smith & Nephew plc (LON:SN.) Delivered A Better ROE Than The Industry, Here’s Why

    Smith & Nephew plc (LSE:SN.) delivered an ROE of 16.52% over the past 12 months, which is an impressive feat relative to its industry average of 10.23% during the sameRead More...

  • Former Alere CEO named to head another medical device giant
    American City Business Journals4 months ago

    Former Alere CEO named to head another medical device giant

    One of Massachusetts’ largest medical device employers, London-based Smith & Nephew, has named a new CEO who’ll be familiar to that company’s 1,100 Massachusetts employees.

  • Reuters4 months ago

    Smith & Nephew picks new CEO who sold his last company

    Artificial hip and knee maker Smith & Nephew (SN.L), a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making. Namal Nawana, who will replace Olivier Bohuon as CEO of the British company next month, most recently headed medical diagnostics firm Alere, where he oversaw its $5.3 billion sale to Abbott (ABT.N) in 2017. The medical technology firm, which also has wound-care and sports medicine units, is under pressure to improve margins and find new sources of growth as it competes with bigger rivals.

  • Smith & Nephew (SNN): Moving Average Crossover Alert
    Zacks5 months ago

    Smith & Nephew (SNN): Moving Average Crossover Alert

    Smith & Nephew plc (SNN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front

  • Manufacturing company adding 100 jobs in Fort Worth in $29M expansion
    American City Business Journals5 months ago

    Manufacturing company adding 100 jobs in Fort Worth in $29M expansion

    Medical equipment supplier Smith & Nephew Inc. has selected its Fort Worth facility to locate a $29 million project, creating 100 new jobs. Fort Worth beat out at least three other cities for the project.

  • PR Newswire5 months ago

    Smith & Nephew Supports AAFAO Courses with Donation of More Than $3M of Equipment to The Podiatry Institute

    LSE:SN), the global medical technology business, today announces the donation of more than $3M of trauma plates and screws, external fixation implants and instruments to The Podiatry Institute (PI). This equipment will be used to support ongoing educational courses conducted at the PI through the American Academy of Foot and Ankle Osteosynthesis (AAFAO). Smith & Nephew has been the sole sponsor of the comprehensive and advanced educational courses conducted by the PI and AAFAO for the past four years, contributing to resident education for nearly 1600 participants.

  • Does Smith & Nephew plc’s (LON:SN.) -2.17% Earnings Drop Reflect A Longer Term Trend?
    Simply Wall St.5 months ago

    Does Smith & Nephew plc’s (LON:SN.) -2.17% Earnings Drop Reflect A Longer Term Trend?

    Measuring Smith & Nephew plc’s (LSE:SN.) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceedRead More...

  • CNW Group5 months ago

    IIROC Trade Resumption - SNN

    IIROC Trade Resumption - SNN

  • PR Newswire5 months ago

    IIROC Trade Resumption - SNN

    VANCOUVER , March 7, 2018 /CNW/ - Trading resumes in: Company: Sunniva Inc. CSE Symbol: SNN Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security ...